Protalix BioTherapeutics Appoints Eliot Richard Forster To Succeed Zeev Bronfeld As Chairman

RTTNews | 784 dagar sedan
Protalix BioTherapeutics Appoints Eliot Richard Forster To Succeed Zeev Bronfeld As Chairman

(RTTNews) - Biopharmaceutical company Protalix BioTherapeutics, Inc. (PLX) announced Tuesday that the Company's Board of Directors has appointed Eliot Richard Forster to serve on the Board of Directors as its Chairman, effective as of September 14, 2023.

In addition to Forster's appointment as Chairman and an independent director, he was also appointed to serve on the Company's Nominating Committee. Zeev Bronfeld, the current Chairman of the Company's Board of Directors, will retire on the same day.

Forster currently serves as the Non-Executive Chairman of Avacta Group PLC (AVCT), as a Non-Executive Director of Immatics NV (IMTX) and as the Non-Executive Chairman of Ochre Bio, Inc., a private biotechnology company.

Forster served as the Chief Executive Officer of F-Star Therapeutics Ltd., a clinical-stage bispecific antibodies company, until its March 2023 sale to inovoX Ltd. Prior to that, he served as CEO of Immunocure Ltd., CEO of Creabilis SA and President and CEO of Solace Pharmaceuticals Inc., each of which was a privately-held life science company.

Earlier in his career, he held positions at Pfizer Global Research & Development and Glaxo/GlaxoWellcome.

read more
Chiesi, Protalix Receive Positive CHMP Opinion For Pegunigalsidase Alfa To Treat Fabry Disease

Chiesi, Protalix Receive Positive CHMP Opinion For Pegunigalsidase Alfa To Treat Fabry Disease

Protalix BioTherapeutics, Inc. (PLX) and Chiesi Global Rare Diseases, a business unit of the Chiesi Group, announced Friday that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion, recommending marketing authorization for PRX-102 (pegunigalsidase alfa), the first and only pegylated enzyme for the treatment of adult patients with Fabry disease.
RTTNews | 984 dagar sedan
Commodity Currency's Slide Amid Risk-Off Sentiment

Commodity Currency's Slide Amid Risk-Off Sentiment

The commodity currencies such as Australia, the New Zealand and the Canadian dollars weakened against other major currencies in the Asian session on Tuesday, as Asian stocks traded lower as a tech rally fizzled out due to valuation concerns and investors weighed mixed messages from Federal Reserve officials over the path of interest rates.
RTTNews | 1h 26minuter sedan
European Shares Decline Amid Risk-off Sentiment

European Shares Decline Amid Risk-off Sentiment

European stocks were sharply lower on Tuesday as mixed earnings, weak U.S. manufacturing data and cautious comments from Federal Reserve officials over the path of interest rates soured investors' appetite for riskier assets.
RTTNews | 2h 7minuter sedan
Yen Rises Against Majors

Yen Rises Against Majors

The Japanese yen strengthened against other major currencies in the Asian session on Tuesday.
RTTNews | 2h 26minuter sedan
Asian Shares Decline Amid Economic Uncertainty

Asian Shares Decline Amid Economic Uncertainty

Asian stocks ended mostly lower on Tuesday as a tech rally fizzled out due to valuation concerns and investors weighed mixed messages from Federal Reserve officials over the path of interest rates.
RTTNews | 2h 35minuter sedan
NZ Dollar Slides Against Majors

NZ Dollar Slides Against Majors

The New Zealand dollar weakened against other major currencies in the Asian session on Tuesday.
RTTNews | 3h 10minuter sedan